Mirum Pharmaceuticals Stock Price Prediction
| MIRM Stock | USD 46.65 1.50 3.32% |
Oversold Vs Overbought
76
Oversold | Overbought |
EPS Estimate Next Quarter (0.39) | EPS Estimate Current Year (1.46) | EPS Estimate Next Year (0.61) | Wall Street Target Price 62.5455 | EPS Estimate Current Quarter (0.45) |
Using Mirum Pharmaceuticals hype-based prediction, you can estimate the value of Mirum Pharmaceuticals from the perspective of Mirum Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mirum Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Mirum because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mirum Pharmaceuticals after-hype prediction price | USD 46.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mirum |
Mirum Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Mirum Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mirum Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mirum Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mirum Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Mirum Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mirum Pharmaceuticals' historical news coverage. Mirum Pharmaceuticals' after-hype downside and upside margins for the prediction period are 43.92 and 48.62, respectively. We have considered Mirum Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mirum Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Mirum Pharmaceuticals is based on 3 months time horizon.
Mirum Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mirum Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mirum Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mirum Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 2.35 | 0.38 | 0.02 | 9 Events / Month | 14 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
46.65 | 46.27 | 0.81 |
|
Mirum Pharmaceuticals Hype Timeline
Mirum Pharmaceuticals is now traded for 46.65. The entity has historical hype elasticity of -0.38, and average elasticity to hype of competition of 0.02. Mirum is projected to decline in value after the next headline, with the price expected to drop to 46.27. The average volatility of media hype impact on the company price is about 136.63%. The price decrease on the next news is expected to be -0.81%, whereas the daily expected return is now at 0.22%. The volatility of related hype on Mirum Pharmaceuticals is about 2421.21%, with the expected price after the next announcement by competition of 46.67. About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.08. Mirum Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Mirum Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Mirum Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Mirum Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Mirum Pharmaceuticals' future price movements. Getting to know how Mirum Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mirum Pharmaceuticals may potentially react to the hype associated with one of its peers.
Mirum Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Mirum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mirum using various technical indicators. When you analyze Mirum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mirum Pharmaceuticals Predictive Indicators
The successful prediction of Mirum Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mirum Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mirum Pharmaceuticals based on analysis of Mirum Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mirum Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mirum Pharmaceuticals's related companies. | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.42 | 6.34 | 6.66 | Days Of Inventory On Hand | 164.15 | 173.13 | 230.08 |
Story Coverage note for Mirum Pharmaceuticals
The number of cover stories for Mirum Pharmaceuticals depends on current market conditions and Mirum Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mirum Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mirum Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Mirum Pharmaceuticals Short Properties
Mirum Pharmaceuticals' future price predictability will typically decrease when Mirum Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mirum Pharmaceuticals often depends not only on the future outlook of the potential Mirum Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mirum Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.9 M | |
| Cash And Short Term Investments | 286.3 M |
Check out Mirum Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 6.513 | Quarterly Revenue Growth 0.894 | Return On Assets (0.09) | Return On Equity (0.40) |
The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.